T cell treatment with small interfering RNA for suppressor of cytokine signaling 3 modulates allergic airway responses in a murine model of asthma

Atsushi Moriwaki, Hiromasa Inoue, Takako Nakano, Yuko Matsunaga, Yukiko Matsuno, Takafumi Matsumoto, Satoru Fukuyama, Keiko Kan-o, Koichiro Matsumoto, Miyuki Tsuda-Eguchi, Daisuke Nagakubo, Osamu Yoshie, Akihiko Yoshimura, Masato Kubo, Yoichi Nakanishi

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

CD4+ T cells, particularly T helper (Th) 2 cells, play a pivotal role in the pathophysiology of allergic asthma. Suppressor of cytokine signaling (SOCS) proteins control the balance of CD4+ T cell differentiation. Mice that lack SOCS3 in T cells by crossing SOCS3-floxed mice with Lck-Cre-transgenic mice have reduced allergen-induced eosinophilia in the airways. Here, we studied the effects of SOCS3 silencing with small interfering (si) RNA in primary CD4+ T cells on Th2 cell differentiation and on asthmatic responses in mice. Th2 cells were generated from ovalbumin (OVA)-specific T cell receptor-transgenic mice in vitroandtransferred into recipient mice. Transfection of SOCS3-specific siRNA attenuated Th2 response in vitro. Adoptive transfer of SOCS3-siRNAT cells exhibited markedly suppressed airway hyperresponsiveness and eosinophilia after OVA challenge, with a concomitant decrease in OVA-specific CD4+ T cell accumulation in the airways. To investigate the mechanism of this impaired CD4+ T cell accumulation, we inactivated SOCS3 of T cells by crossing SOCS3-floxed (SOCS3 flox/flox) mice with CD4-Cre transgenic mice. CD4-Cre x SOCS3 flox/flox mice exhibited fewer IL-4-producing cells and more reduced eosinophil infiltration in bronchoalveolar lavage fluids than control mice in a model of OVA-induced asthma. Expression of CCR3 and CCR4 in CD4+ T cells was decreased in CD4-Cre x SOCS3flox/flox mice. CCR4 expression was also decreased in CD4+ T cells after transfer of SOCS3 siRNA-treated T cells. These findings suggest that the therapeutic modulation of SOCS3 expression in CD4+ T cells might be effective in preventing the development of allergic asthma.

Original languageEnglish
Pages (from-to)448-455
Number of pages8
JournalAmerican journal of respiratory cell and molecular biology
Volume44
Issue number4
DOIs
Publication statusPublished - Apr 1 2011

All Science Journal Classification (ASJC) codes

  • Molecular Biology
  • Pulmonary and Respiratory Medicine
  • Clinical Biochemistry
  • Cell Biology

Fingerprint Dive into the research topics of 'T cell treatment with small interfering RNA for suppressor of cytokine signaling 3 modulates allergic airway responses in a murine model of asthma'. Together they form a unique fingerprint.

  • Cite this

    Moriwaki, A., Inoue, H., Nakano, T., Matsunaga, Y., Matsuno, Y., Matsumoto, T., Fukuyama, S., Kan-o, K., Matsumoto, K., Tsuda-Eguchi, M., Nagakubo, D., Yoshie, O., Yoshimura, A., Kubo, M., & Nakanishi, Y. (2011). T cell treatment with small interfering RNA for suppressor of cytokine signaling 3 modulates allergic airway responses in a murine model of asthma. American journal of respiratory cell and molecular biology, 44(4), 448-455. https://doi.org/10.1165/rcmb.2009-0051OC